Loading…

Evidence for reduced neuromuscular function in men with a history of androgen deprivation therapy for prostate cancer

Summary Background Indices of body composition and muscular strength were compared between men with prostate cancer (PCa) treated with androgen deprivation therapy (ADT) and asymptomatic matched men. Methods Nine subjects aged 63–83 years with PCa who received ADT (PCa+ADT; duration 6–180 months) an...

Full description

Saved in:
Bibliographic Details
Published in:Clinical physiology and functional imaging 2014-05, Vol.34 (3), p.209-217
Main Authors: Girard, Danielle, Marino, Frank E., Cannon, Jack
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Summary Background Indices of body composition and muscular strength were compared between men with prostate cancer (PCa) treated with androgen deprivation therapy (ADT) and asymptomatic matched men. Methods Nine subjects aged 63–83 years with PCa who received ADT (PCa+ADT; duration 6–180 months) and 11 asymptomatic aged‐matched eugonadal men (HM) aged 59–80 years were assessed for prostate‐specific antigen (PSA) and total testosterone (TT). Total body non‐osseous lean mass (TBLM) and right thigh non‐osseous fat‐free mass (RTLM) were assessed using dual‐energy X‐ray absorptiometry. Peak torque of the right knee extensors at 0° s−1 (ISO) and 60° s−1 (CON), maximal handgrip strength of the dominant hand (MHS) and whole‐body strength (WBS) were assessed. ISO and CON per unit mass of RTLM and MHS and WBS per unit mass of TBLM were calculated. Results Age, height, mass, body mass index and prostate‐specific antigen were comparable between groups (P>0·05), while TT was lower in PCa+ADT (P
ISSN:1475-0961
1475-097X
DOI:10.1111/cpf.12084